Insight Molecular Diagnostics Inc. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
Insight Molecular Diagnostics Inc. (IMDX) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $370.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-19.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2021-03-19
- Insight Molecular Diagnostics Inc. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2019 was $370.00K.
- Insight Molecular Diagnostics Inc. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2017 was $4.07M.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|
| 2019-12-31 | $370.00K 10-K · filed 2021-03-19 |
| 2017-12-31 | $4.07M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |